These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11703423)

  • 41. Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study.
    Thomas X; Boiron JM; Huguet F; Reman O; Sutton L; Turlure P; Garban F; Gardin C; Espinouse D; Boulat O; Lhéritier V; Fiere D;
    Hematol J; 2004; 5(5):384-94. PubMed ID: 15448664
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhancement of neutrophil function by in vivo filgrastim treatment for prophylaxis of sepsis in surgical intensive care patients.
    Weiss M; Gross-Weege W; Schneider M; Neidhardt H; Liebert S; Mirow N; Wernet P
    J Crit Care; 1995 Mar; 10(1):21-6. PubMed ID: 7538851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis.
    Miura E; Procianoy RS; Bittar C; Miura CS; Miura MS; Mello C; Christensen RD
    Pediatrics; 2001 Jan; 107(1):30-5. PubMed ID: 11134430
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recombinant human G-CSF and GM-CSF prime human neutrophils for superoxide production through different signal transduction mechanisms.
    Balazovich KJ; Almeida HI; Boxer LA
    J Lab Clin Med; 1991 Dec; 118(6):576-84. PubMed ID: 1720802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.
    Winter JN; Lazarus HM; Rademaker A; Villa M; Mangan C; Tallman M; Jahnke L; Gordon L; Newman S; Byrd K; Cooper BW; Horvath N; Crum E; Stadtmauer EA; Conklin E; Bauman A; Martin J; Goolsby C; Gerson SL; Bender J; O'Gorman M
    J Clin Oncol; 1996 Jan; 14(1):277-86. PubMed ID: 8558209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcomes of granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor use in neutropenic patients infected with human immunodeficiency virus.
    Ambati BK; Perlman DC; Salomon N
    Int J Infect Dis; 1998-1999 Winter; 3(2):70-5. PubMed ID: 10225983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clonal growth of functionally normal and deficient neutrophils from the bone marrow of a patient with variant chronic granulomatous disease. Lack of reconstitution of oxidative burst defect by G-CSF, GM-CSF, and IFN-gamma in vitro.
    Oez S; Birkmann J; Kalden JR
    Ann Hematol; 1993 Jan; 66(1):21-5. PubMed ID: 7679293
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte-macrophage colony-stimulating factor in neutropenic children with malignancies.
    Lydaki E; Bolonaki E; Stiakaki E; Dimitriou H; Kalmantis T; Kalmanti M
    Pediatr Hematol Oncol; 1995; 12(6):551-8. PubMed ID: 8589000
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo effect of recombinant human granulocyte colony-stimulating factor on phagocytic function and oxidative burst activity in septic neutropenic neonates.
    Ahmad M; Fleit HB; Golightly MG; La Gamma EF
    Biol Neonate; 2004; 86(1):48-54. PubMed ID: 15057022
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of recombinant human granulocyte and granulocyte-macrophage colony-stimulating factors on neutrophil function following autologous bone marrow transplantation.
    Gadish M; Kletter Y; Flidel O; Nagler A; Slavin S; Fabian I
    Leuk Res; 1991; 15(12):1175-82. PubMed ID: 1722549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The neutrophil, not the tumor: serum CA 15-3 elevation as a result of granulocyte--colony-stimulating factor-induced neutrophil MU1C overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapy.
    Pentheroudakis G; Malamou-Mitsi V; Briasoulis E; Damala K; Vassou A; Vartholomatos G; Kolaitis N; Pavlidis N
    Cancer; 2004 Oct; 101(8):1767-75. PubMed ID: 15386335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prevention and treatment of febrile neutropenia].
    Montemurro F; Gallicchio M; Aglietta M
    Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Granulocyte-colony stimulating factor administration for neurological improvement in patients with postrehabilitation chronic incomplete traumatic spinal cord injuries: a double-blind randomized controlled clinical trial.
    Derakhshanrad N; Saberi H; Yekaninejad MS; Joghataei MT; Sheikhrezaei A
    J Neurosurg Spine; 2018 Jul; 29(1):97-107. PubMed ID: 29701561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of intra-abdominal infection with granulocyte colony-stimulating factor.
    O'Reilly M; Silver GM; Greenhalgh DG; Gamelli RL; Davis JH; Hebert JC
    J Trauma; 1992 Nov; 33(5):679-82. PubMed ID: 1281510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neutrophil apoptosis, activation and anti-inflammatory cytokine response in granulocyte colony-stimulating factor-treated patients with community-acquired pneumonia.
    Droemann D; Hansen F; Aries SP; Braun J; Zabel P; Dalhoff K; Schaaf B
    Respiration; 2006; 73(3):340-6. PubMed ID: 16369129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Study of the prophylactic effect of human granulocyte-colony stimulating factor (G-CSF) on experimental pyelonephritis induced by Pseudomonas aeruginosa in diabetic mice].
    Yokoo A; Kumamoto Y; Hirose T; Tanaka N
    Kansenshogaku Zasshi; 1989 Jul; 63(7):738-47. PubMed ID: 2482317
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhG-CSF).
    Tamai H; Mukuta T; Matsubayashi S; Fukata S; Komaki G; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1356-60. PubMed ID: 7521347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Granulocyte colony-stimulating factor improves host defense to resuscitated shock and polymicrobial sepsis without provoking generalized neutrophil-mediated damage.
    Patton JH; Lyden SP; Ragsdale DN; Croce MA; Fabian TC; Proctor KG
    J Trauma; 1998 May; 44(5):750-8; discussion 758-9. PubMed ID: 9603074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beneficial effect of recombinant human granulocyte colony-stimulating factor on fungicidal activity of polymorphonuclear leukocytes from patients with AIDS.
    Vecchiarelli A; Monari C; Baldelli F; Pietrella D; Retini C; Tascini C; Francisci D; Bistoni F
    J Infect Dis; 1995 Jun; 171(6):1448-54. PubMed ID: 7539473
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function.
    Molloy EJ; O'Neill AJ; Grantham JJ; Sheridan-Pereira M; Fitzpatrick JM; Webb DW; Watson RW
    Pediatr Res; 2005 Jun; 57(6):806-12. PubMed ID: 15718363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.